Brief report: Association of genetic variants in the IL4 and IL4R genes with the severity of joint damage in rheumatoid arthritis: A study in seven cohorts

Arthritis and Rheumatism

Volumn 65, Issue 12, 2013, Pages 3051-3057

  Krabben, A ^a   Wilson, A G ^b   De Rooy, D P C ^a   Zhernakova, A ^a,c   Brouwer, E ^c   Lindqvist, E ^d   Saxne, T ^d   Stoeken, G ^a   Van Nies, J A B ^a   Knevel, R ^a   Huizinga, T W J ^a   Toes, R ^a   Gregersen, P K ^e   Van Der Helm Van Mil, A H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d LUND UNIVERSITY   (Sweden)

^e FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

ADULT; ARTHROPATHY; ARTICLE; COHORT ANALYSIS; DATA BASE; DISEASE COURSE; FEMALE; FOLLOW UP; FOOT RADIOGRAPHY; GENE; GENETIC VARIABILITY; GENOTYPE; HAND RADIOGRAPHY; HAPLOTYPE; HUMAN; IL4 GENE; IL4R GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ALLELE; FOOT; GENETICS; HAND JOINT; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ALLELES; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; FEMALE; FOOT JOINTS; GENOTYPE; HAND JOINTS; HUMANS; INTERLEUKIN-4; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-4; SEVERITY OF ILLNESS INDEX;

EID: 84889022684     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.38141     Document Type: Article

References (20)

1. Knevel R, Krabben A, Brouwer E, Posthumus MD, Wilson AG, Lindqvist E, et al. Genetic variants in IL15 associate with progression of joint destruction in rheumatoid arthritis: a multicohort study. Ann Rheum Dis 2012; 71: 1651-7.
2. Knevel R, Grondal G, Huizinga TW, Visser AW, Jonsson H, Vikingsson A, et al. Genetic predisposition of the severity of joint destruction in rheumatoid arthritis: a population-based study. Ann Rheum Dis 2012; 71: 707-9.
3. Van Roon JA, Verhoef CM, van Roy JL, Gmelig-Meyling FH, Huber-Bruning O, Lafeber FP, et al. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Ann Rheum Dis 1997; 56: 656-60.
4. Miossec P, Naviliat M, Dupuy D'Angeac A, Sany J, Banchereau J,. Low levels of interleukin-4 and high levels of transforming growth factor β in rheumatoid synovitis. Arthritis Rheum 1990; 33: 1180-7.
5. Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther 2005; 7: R784-95.
6. Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, et al. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Arthritis Rheum 2008; 58: 2397-408.
7. Genevay S, Di Giovine FS, Perneger TV, Silvestri T, Stingelin S, Duff G, et al. Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis. Arthritis Rheum 2002; 47: 303-9.
8. Prots I, Skapenko A, Wendler J, Mattyasovszky S, Yone CL, Spriewald B, et al. Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis. Arthritis Rheum 2006; 54: 1491-500.
9. Marinou I, Till SH, Moore DJ, Wilson AG,. Lack of association or interactions between the IL-4, IL-4Rα and IL-13 genes, and rheumatoid arthritis. Arthritis Res Ther 2008; 10: R80.
10. Burgos PI, Causey ZL, Tamhane A, Kelley JM, Brown EE, Hughes LB, et al. Association of IL4R single-nucleotide polymorphisms with rheumatoid nodules in African Americans with rheumatoid arthritis. Arthritis Res Ther 2010; 12: R75.
11. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
12. Van der Heijde DM, van Riel PL, Gribnau FW, Nuver-Zwart IH, van de Putte LB,. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1989; 1: 1036-8.
13. Fex E, Jonsson K, Johnson U, Eberhardt K,. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis: a prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996; 35: 1106-15.
14. Jawaheer D, Seldin MF, Amos CI, Chen WV, Shigeta R, Etzel C, et al, for the North American Rheumatoid Arthritis Consortium. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum 2003; 48: 906-16.
15. Mewar D, Coote A, Moore DJ, Marinou I, Keyworth J, Dickson MC, et al. Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006; 8: R128.
16. Wolfe F, Michaud K,. The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank. Rheumatology (Oxford) 2011; 50: 16-24.
17. Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, et al. Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis. Scand J Rheumatol 2013; 42: 182-9.
18. Lassere M,. Pooled metaanalysis of radiographic progression: comparison of Sharp and Larsen methods. J Rheumatol 2000; 27: 269-75.
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-9.
20. Wallis SK, Cooney LA, Endres JL, Lee MJ, Ryu J, Somers EC, et al. A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R15.